
Read More
This Low PE Pharma Stock Jumps Up to 10% After USFDA Clearance; Receives EI...
Strides Pharma Science received the USFDA Establishment Inspection Report for its flagship Bengaluru...

Strides Pharma Science received the USFDA Establishment Inspection Report for its flagship Bengaluru...

From Rs 129 to Rs 916, the stock has delivered returns of around 610 per cent...

The company has been actively expanding its product pipeline, with over 70 commercialized products a...

The stock gave multibagger returns of over 200 per cent in just 1 year and a whopping 400 per cent i...

Of significant note is the remarkable reduction in the company's debt-to-EBITDA ratio, which has und...

The stock has surged nearly 107 per cent in the last year, transforming into a multibagger stock for...